Status:
COMPLETED
Two Inhalation Methods Using a Pressurized Metered Dose Inhaler With Valved Holding Chamber to Assess Improvement in Lung Function After SABA Administration in Bronchial Asthma
Lead Sponsor:
Post Graduate Institute of Medical Education and Research, Chandigarh
Conditions:
Bronchial Asthma
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Bronchial asthma is a chronic inflammatory disorder characterized by recurrent reversible episodes of breathlessness, wheezing, chest tightness and/ or cough. The prevalence of asthma in India is abou...
Detailed Description
Bronchial asthma is a chronic inflammatory disorder characterized by recurrent reversible episodes of breathlessness, wheezing, chest tightness and/ or cough.1 The prevalence of asthma in India is abo...
Eligibility Criteria
Inclusion
- (a) Patients with a physician diagnosis of bronchial asthma undergoing spirometry (b) ability to provide informed consent to participate in the study
Exclusion
- (a) Patients having active pulmonary tuberculosis; (b) pregnancy; (c) patients already on inhaled or oral bronchodilators or corticosteroids as part of asthma treatment; and, (d) failure to provide informed consent
Key Trial Info
Start Date :
June 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2023
Estimated Enrollment :
897 Patients enrolled
Trial Details
Trial ID
NCT05428956
Start Date
June 15 2022
End Date
May 31 2023
Last Update
November 18 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Bronchoscopy suite, PGIMER
Chandigarh, India, 160012
2
Chest clinic
Chandigarh, India, 160012